Onesource Specialty Pharma informs about updates
Date: 02-04-2026Onesource Specialty Pharma has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship.
The above information is a part of company’s filings submitted to BSE.